SCHEMBL13749693

SCHEMBL13749693

C/C=C(\CN)Cc1cc2ccccc2s1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 5/20 0.57
ASIC3 Q9UHC3 1/20 0.57
LOXL2 Q9Y4K0 1/20 0.57
AGXT P21549 1/20 0.49
ADRB2 P07550 1/20 0.49
IDH1 O75874 1/20 0.40
GLS O94925 2/20 0.40
ADRA1D P25100 2/20 0.38
ALOX5 P09917 3/20 0.38
CYP1A2 P05177 2/20 0.38
PTGES O14684 1/20 0.38
LMNA P02545 1/20 0.38
LTA4H P09960 1/20 0.38
GAA P10253 1/20 0.38
ALOX15 P16050 1/20 0.38
ALOX12 P18054 1/20 0.38
ALOX5AP P20292 1/20 0.38
LOX P28300 1/20 0.38
EPHX2 P34913 1/20 0.38
PTGS2 P35354 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1295058 0.86 CYP2A6 (0.56) CYP2A6ASIC3LOXL2AGXTADRB2
SCHEMBL1295061 0.86 CYP2A6 (0.56) CYP2A6ASIC3LOXL2AGXTADRB2
SCHEMBL1295137 0.86 CYP2A6 (0.56) CYP2A6ASIC3LOXL2AGXTADRB2
SCHEMBL19821752 0.77 CYP2A6 (0.59) CYP2A6ASIC3LOXL2AGXTADRB2
SCHEMBL5538543 0.76 CYP2A6 (0.63) CYP2A6ASIC3LOXL2AGXTADRB2
SCHEMBL21697570 0.75 CYP2A6 (0.49) CYP2A6ASIC3LOXL2AGXTADRB2
SCHEMBL21697569 0.74 CYP2A6 (0.56) CYP2A6ASIC3LOXL2AGXTADRB2
SCHEMBL240588 0.74 CYP2A6 (1.00) CYP2A6ASIC3LOXL2AGXTADRB2
SCHEMBL1029348 0.73 CYP2A6 (0.59) CYP2A6ASIC3LOXL2AGXTADRB2
Hydrochloric Acid SCHEMBL6941951 0.72 CYP2A6 (0.96) CYP2A6ASIC3LOXL2AGXTADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203764-A1 INHIBITORS OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) AND VAP-1 MEDIATED ADHESION USEFUL FOR TREATMENT AND PREVENTION OF DISEASES FASTRACK PHARMACEUTICALS, INC. 2009-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203764-A1 INHIBITORS OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) AND VAP-1 MEDIATED ADHESION USEFUL FOR TREATMENT AND PREVENTION OF DISEASES VCAM1, AOC3, AOC2 CYP2A6 3826/4885ASIC3 723/4885LOXL2 160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.